Over time, a simple narrative has taken hold: that physicians and APPs are increasingly in competition with one another. In ...

Bristol-Myers Squibb and BioNTech are launching ROSETTA HCC-206, an early-stage clinical trial in advanced or inoperable liver cancer (hepatocellular carcinoma). The study, officially titled “ROSETTA ...

As advanced practice providers (APPs) with Legacy continue their strike, APPs from Legacy GoHealth urgent care clinics are ...

Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...

Five years ago quarterbacks around the league threw for an average of 240.2 yards per game. Now that has plummeted to 212.3 ...

The launch also reinforces Cata-Kor’s positioning within the U.S. longevity segment. Over recent years, the brand has become closely associated with science-driven healthy-ageing solutions, and the ...

Five towns have formally opposed the Glassboro-Camden Light Rail through resolutions or referendums, but NJ Transit is ...

Industry leaders say spectrum clarity, AI-native networks and ecosystem coordination will define the next phase of ultra-wideband connectivity and lay the foundations for future 6G services.

The National Institute for Health and Care Excellence (NICE) has recommended amivantamab (Rybrevant) plus lazertinib (Lazcluze) as a first-line option for adults with previously untreated advanced non ...

Over the past few days, both Ukrainian and Russian forces have been advancing on the front lines, with the situation in the ...

Young Tiger Woods—which I'm defining here as the period before he turned 30, encompassing eight major wins from his 1997 ...

SportsLine's model reveals its New England Patriots vs. Baltimore Ravens best bets for 'Sunday Night Football' ...